<div id="firstBodyDiv" data-bind-html-content-type="article" data-bind-html-compile="article.body" data-first-article-body="
A one-year study found that "دوستارليماب" which is used in the treatment of Cancer liner the womb when WomenIt helped cure 18 patients colon cancer and rectum, participated in this clinical trial.
Commenting on this medical discovery, a member of the US National Advisory Board said for cancerand lead author of the study, Dr. Luis Diaz, said the experiment is a "An important step in the battle against cancer. We will conduct more research to find out the effect of the drug on other types of cancer, such as stomach والبروستات والبنكرياس"according to the newspaper "Daily Mail" British.
According to researchers, it can be used "دوستارليماب" With patients with tumors of a specific genetic makeup known as microsatellite instability or MSI.
The drug’s monoclonal antibody works by binding to a protein called PD-1 on the surface of the drug cancer cellsThis helps the immune system to effectively destroy cancer cells.
The researchers confirmed the study, which was published in the journal "New England" medical it: "At the time of writing, no patient had received chemotherapy or radiotherapy or had surgery, and no cases of cancer development or recurrence had been reported during follow-up.".
While presenting the findings at the annual meeting of the American Society of Clinical Oncology, Dr. Andrea Krecek, an oncologist at Memorial Sloan Kettering Cancer Center and co-author of the study, said: "The treatment will help rid patients of harsh forms of treatment such as surgery and chemotherapyConditions affecting fertility, organ function and sexual health, as well as side effects such as rash, fatigue and nausea".
Despite the promising results of the drug "the miracle"However, the researchers stressed the need for more research to be conducted on a larger number of people, to monitor the length of time during which the drug should be taken, and to evaluate the few side effects of the experiment.
It is worth noting that about 43,000 Britons and 150,000 Americans are diagnosed with colorectal cancer each year, and they kill 17,000 and 53,000 each year in both the United Kingdom and America.
“>
And a one-year study concluded that the drug “dostarlimab”, which is used to treat… Cancer liner the womb when WomenIt helped cure 18 patients colon cancer and rectum, participated in this clinical trial.
Commenting on this medical discovery, a member of the US National Advisory Board said for cancerAnd lead author of the study, Dr. Luis Diaz, said the trial is an “important step in the battle against cancer. We will conduct more research to find out the effect of the drug on other types of cancer such as stomach”. والبروستات and pancreas,” according to the British newspaper, “Daily Mail”.
According to the researchers, “dostarlimab” can be used in patients with tumors with a specific genetic makeup known as microsatellite instability, or MSI.
The drug’s monoclonal antibody works by binding to a protein called PD-1 on the surface of the drug cancer cellsThis helps the immune system to effectively destroy cancer cells.
In the study published in the New England Journal of Medicine, the researchers emphasized that: “At the time of writing this report, no patient had received chemotherapy or radiotherapy or had surgery, and no cases of cancer development or recurrence had been reported during follow-up.”
Presenting the findings at the annual meeting of the American Society of Clinical Oncology, Dr Andrea Krecek, a clinical oncologist at Memorial Sloan Kettering Cancer Center and co-author of the study, said: “The treatment will free patients from harsh forms of treatment such as surgery. and chemotherapyConditions affecting fertility, organ function and sexual health, as well as side effects such as rash, fatigue and nausea.
Despite the promising results of the “miracle” drug, the researchers stressed the need to conduct more research on a larger number of people, monitor the length of time during which the drug should be taken, and evaluate the few side effects of the experiment.
It is worth noting that about 43,000 Britons and 150,000 Americans are diagnosed with colorectal cancer each year, and they kill 17,000 and 53,000 each year in both the United Kingdom and America.